General Information of the Compound
Compound ID
CP0430002
Compound Name
3-naphthalen-2-yl-5-piperidin-4-yl-1,2,4-oxadiazole
    Show/Hide
Structure
Formula
C17H17N3O
Molecular Weight
279.343
Canonical SMILES
C1CC(CCN1)c1nc(no1)-c1ccc2ccccc2c1
    Show/Hide
InChI
InChI=1S/C17H17N3O/c1-2-4-14-11-15(6-5-12(14)3-1)16-19-17(21-20-16)13-7-9-18-10-8-13/h1-6,11,13,18H,7-10H2
    Show/Hide
InChIKey
PPCNFLPYHQIYHP-UHFFFAOYSA-N
Physicochemical Property
logP
3.3568
Rotatable Bonds
2
Heavy Atom Count
21
Polar Areas
50.95
Hydrogen Bond Donor Count
1
Hydrogen Bond Acceptor Count
4
Complexity
21

"RO5" indicates the cutoff set by lipinski's rule of five:

(1) Molecular weight less than 500 Dalton;

(2) xlogp less than 5;

(3) No more than 5 hbonddonor (Hydrogen Bond Donor Count);

(4) No more than 10 hbondacc (Hydrogen Bond Acceptor Count);

(5) No more than 10 rotbonds (Rotatable Bond Count).

    Show/Hide
Click to Show/Hide the External Link(s) of This Compound
PubChem ID
CID: 62715191
ChEMBL ID
CHEMBL4464270
Map of Molecular Bioactivity Related to the Compound
Map of Molecular Bioactivity Related to the Compound

Compound
Cell Line
Protein

Bioactivity Value:

<= 0.1 μM
> 0.1 μM and <= 10 μM
> 10 μM
Imprecise Activity
Table of Molecular Bioactivities Related to the Compound
Protein ID: PT01286, Bile acid receptor
Cell-based Assay
Cell Line ID Cell Line Name Cell Line Organism
CL000063 Hep-G2 Homo sapiens (Human)  1
1
IC50 = 580 nM
   TI
   LI
   LO
   TS